Pharmacists News

• EPA 2020Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms Cariprazine is more effective than risperidone for persistent negative symptoms in schizophrenia and appears to be effective in patients resistant to previous treatment with other antipsychotic agents.
  Medscape Medical News, July 09, 2020
• IAS 2020Injection Beats Pill for Long-Lasting HIV Prevention A long-lasting option for pre-exposure prophylaxis looks promising for people who have an issue with a daily pill, but some experts are urging the company to delay its application for approval.
  Medscape Medical News, July 09, 2020
• Can DBS in Early Parkinson's Disease Reduce Disease Progression? Compared with standard treatment, DBS plus drug therapy appears to reduce the need for polypharmacy.
  Medscape Medical News, July 09, 2020
• ATS 2020Treprostinil Improves Walk Distance in Pulmonary Hypertension Exercise capacity increased after patients with pulmonary hypertension associated with interstitial lung disease were treated with the vasodilator for 16 weeks, new research shows.
  Medscape Medical News, July 09, 2020
• New Hope for ALS Two studies using different approaches to suppress a gene linked to amyotrophic lateral sclerosis (ALS) may signal a new approach for treating the disorder.
  Medscape Medical News, July 09, 2020
• US Supreme Court Allows Broader Religious Exemption to Birth Control Coverage The US Supreme Court on Wednesday endorsed a plan by Trump's administration to give employers broad religious and moral exemptions from a federal mandate that health insurance covers women's birth control.
  Reuters Health Information, July 08, 2020
• EU Scrambles to Buy Intensive Care Drugs to Tackle COVID Shortages The EU is seeking firms to supply 24 intensive care drugs, an EU official told Reuters, as it strives to tackle shortages of medicines for COVID-19 patients amid fears of a second wave of infections and strong global demand.
  Reuters Health Information, July 08, 2020
• Flu Drug Blocks Household Spread by 86% A single dose of the influenza drug baloxavir marboxil, if given quickly to the family members, can prevent 86% of parents and siblings from falling ill themselves, according to a new Japanese study.
  Reuters Health Information, July 08, 2020
• Primary Prevention Statins Cut Mortality Even in the Very Elderly With trial data for this age group in short supply, a US veterans cohort study saw a 25% drop in all-cause mortality for those newly starting on a statin at age 75 or older.
  Medscape Medical News, July 09, 2020
• Proton Pump Inhibitors Tied to COVID-19 Risk Use of proton pump inhibitors was associated with increased risk for COVID-19 in a large survey of US adults.
  Medscape Medical News, July 09, 2020
• Biogen Moves Forward With Potential Alzheimer's Drug, Seeks US Approval Biogen said on Wednesday it submitted an application seeking US approval of its closely watched Alzheimer's drug, as the company aims to be the first to bring a treatment to market.
  Reuters Health Information, July 08, 2020
• Steroids Linked to Increased Hypertension in RA The authors found that daily dose appeared to be important in determining risk but that cumulative dose did not.
  Medscape Medical News, July 09, 2020
• COVID-19 Update: Elusive Complication, Remdesivir Toxicity The coronavirus stories Medscape's editors around the globe think you need to know about today.
  Medscape Medical News, July 08, 2020
• Demand for Unproven COVID-19 Remedy Led to Shortages for SLE Patients Pandemic-driven demand for hydroxychloroquine contributed to shortages for patients with systemic lupus erythematosus, according to an international survey of lupus clinics.
  Reuters Health Information, July 07, 2020
• Hepatotoxicity Tied to Remdesivir COVID-19 Treatment Although remdesivir treatment may shorten time to recovery in patients with COVID-19, it may also induce liver injury, possibly in combination with P-glycoprotein inhibitors, according to a case report by Dutch investigators.
  Reuters Health Information, July 07, 2020
• ATS 2020Novel Agent Shows Promise in Bronchiectasis Brensocatib, a small-molecule DPP1 inhibitor, could be a good nonantibiotic option for reducing exacerbations in patients with bronchiectasis, new research shows.
  Medscape Medical News, July 08, 2020
• Alert FDA Approves Oral Therapy for Myelodysplastic Syndromes, CMML The Food and Drug Administration has approved Inqovi (decitabine and cedazuridine tablets, Astex Pharmaceuticals) to treat adults with myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML).
  FDA Approvals, July 08, 2020
• WCGC 2020Drug-Drug Interactions to Avoid in Patients With GI Cancer Patients with gastrointestinal tumors can have potentially life-threatening complications from drug-drug interactions, including, for example, reactions between PPIs and cepacitabine.
  Medscape Medical News, July 08, 2020
• EHRA 2020Hypnosis May Relieve Pain, Morphine Use at AFlut Ablation Standard pain-control methods can pose some risks, so alternatives that curb opiate use during ablation would be welcome, as would larger trials confirming a study hinting at a role for hypnotism.
  Medscape Medical News, July 08, 2020
• Study Shows Benefits of Integrating Dermatology Into Oncology Incorporating skin toxicity protocols at a cancer center significantly increased the rate of prophylactic treatment for rashes resulting from cancer therapies.
  Medscape Medical News, July 08, 2020